Gainers
Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-211.
Grab Hldgs's (NASDAQ:GRAB) short percent of float has risen 17.82% since its last report. The company recently reported that it has 109.98 million shares sold short, which is 4.43% of all regular shares that are available for trading.